|
|
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness |
| 1 R01 DA047301-01A1 |
VILARDAGA, ROGER |
NIDA |
2020 |
|
|
A prospective examination of stimulant diversion and related risk factors for young adults with childhood- or adult-diagnosed ADHD |
| 1 R01 DA049721-01A1 |
MOLINA, BROOKE S G |
NIDA |
2020 |
|
|
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection |
| 1 R01 DA052845-01 |
MOHAN, MAHESH |
NIDA |
2020 |
|
|
Ecological Momentary Assessment of Posttraumatic Stress Disorder and Prenatal Bonding Predicting Opioid Use Disorder Relapse Among Pregnant Women |
| 1 R21 DA048058-01A1 |
SANJUAN, PILAR M |
NIDA |
2020 |
|
|
Cigarette Smoking as a Risk Factor for Greater Psychiatric Symptom Severity across Serious Mental Illnesses: A Secondary Analysis of Three Nationally-Representative NIH Datasets |
| 1 R21 DA051538-01 |
BOND, DAVID J |
NIDA |
2020 |
|
|
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders |
| 2R01DA017846-11A1 |
TEICHER, MARTIN H |
NIDA |
2020 |
|
|
Neuronal Adaptation and Plasticity after Chronic Disuse |
| 2R01MH071739-17 |
TSIEN, RICHARD W |
NIDA |
2020 |
|
|
1/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function |
| 2R01MH095014-06 |
GILBERT, DONALD L |
NIDA |
2020 |
|
|
1/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function |
| 2R01MH095014-06 |
GILBERT, DONALD L |
NIDA |
2020 |
|
|
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo |
| 3R01DA045596-03S1 |
FITTING, SYLVIA |
NIDA |
2020 |
